Anusha Nallaparaju

Anusha Nallaparaju practices at Beth Israel Deaconess Medical Center in Boston, Massachusetts, part of Beth Israel Lahey Health.

Anusha Nallaparaju's NPI, 1922361997, was assigned on June 24, 2012. Anusha Nallaparaju holds Massachusetts license 290843.

Anusha Nallaparaju's primary practice is Beth Israel Deaconess Medical Center, at 330 Brookline Avenue, Boston, MA 02215 in Suffolk County. The practice phone is (617) 667-7000.

Anusha Nallaparaju's primary practice is Beth Israel Deaconess Medical Center in Boston, Massachusetts, part of Beth Israel Lahey Health. Anusha Nallaparaju is also affiliated with Beth Israel Deaconess Hospital-Plymouth. The medical group on file is Harvard Medical Faculty Physicians at Beth Israel Deaconess Medical Center (HMFP). Dmand AI also links Anusha Nallaparaju to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Anusha Nallaparaju practices, 3 sites in all. Vendor and product names are available with a free account.

Vascular neurology is Anusha Nallaparaju's primary specialty in the NPI Registry, under taxonomy code 2084V0102X. Dmand AI has Anusha Nallaparaju's licenses on file in 2 states: Massachusetts and Louisiana.

CMS data shows 474 Medicare services from Anusha Nallaparaju across 9 procedure codes in 2024, for 165 Medicare patients. Medicare paid $49,190 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 165 Medicare patients who saw Anusha Nallaparaju in 2024. The largest group is 75 to 84, with 73 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 25% are also on Medicaid. Their average risk score is 1.48, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Anusha Nallaparaju's median patient age at 73, with 60% women.

In 2024, Anusha Nallaparaju wrote 113 Medicare Part D claims for 24 patients. 91% of them were for generic drugs. CMS names the drug for 49 of them, across 2 drugs with 11 or more claims each, at $421 in total drug cost. In 2021, CMS named 11 claims across 1 drug.

Anusha Nallaparaju accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 2 papers to Anusha Nallaparaju, published from 2024 to 2025. Anusha Nallaparaju's most frequent co-authors are Alexander Andreev, MD, Sandeep Kumar, MD and David Jing Piao Lin, MD.

CMS Open Payments shows 3 general payments to Anusha Nallaparaju from 2 drug and device companies from 2019 to 2020. Food and beverage make up the largest share, 100% of the total. Janssen Pharmaceuticals, Inc paid the most, $35.